| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050697715 |
| P356 | DOI | 10.1186/AR3772 |
| P932 | PMC publication ID | 3446425 |
| P698 | PubMed publication ID | 22410100 |
| P5875 | ResearchGate publication ID | 221695961 |
| P2093 | author name string | Frank P Luyten | |
| Rik J Lories | |||
| Kirsten Braem | |||
| Christophe M Deroose | |||
| P2860 | cites work | Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis | Q28209599 |
| Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis | Q35553008 | ||
| Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes | Q37098884 | ||
| Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years | Q37350944 | ||
| Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis | Q37480069 | ||
| Osteoporosis in inflammatory joint diseases | Q37765505 | ||
| Are current available therapies disease-modifying in spondyloarthritis? | Q37805032 | ||
| Osteoporosis: a paradox in ankylosing spondylitis. | Q37885790 | ||
| Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. | Q40984742 | ||
| Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis | Q41822526 | ||
| Treatment with a novel chemokine-binding protein or eosinophil lineage-ablation protects mice from experimental colitis | Q41851105 | ||
| Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice | Q42486323 | ||
| AMIDE: a free software tool for multimodality medical image analysis | Q42614465 | ||
| Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis | Q43049870 | ||
| Autoradiographic quantification of 18F-FDG uptake in experimental soft-tissue abscesses in rats | Q43984612 | ||
| Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial | Q46525954 | ||
| Inhibition of osteoclasts does not prevent joint ankylosis in a mouse model of spondyloarthritis | Q46707487 | ||
| Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept | Q48533541 | ||
| Species specificity of ectopic bone formation using periosteum-derived mesenchymal progenitor cells | Q48926306 | ||
| The role of bone marrow-derived cells in bone fracture repair in a green fluorescent protein chimeric mouse model. | Q50770703 | ||
| Blocking p38 signalling inhibits chondrogenesis in vitro but not ankylosis in a model of ankylosing spondylitis in vivo. | Q53202747 | ||
| Ankylosing spondylitis | Q54165668 | ||
| Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. | Q55047291 | ||
| The combined bone forming capacity of human periosteal derived cells and calcium phosphates | Q57679365 | ||
| Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis | Q61628500 | ||
| T lymphocytes are not required for the spontaneous development of entheseal ossification leading to marginal ankylosis in the DBA/1 mouse | Q73678538 | ||
| Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis | Q79695019 | ||
| Pro-inflammatory cytokine tumor necrosis factor-alpha induces bone morphogenetic protein-2 in chondrocytes via mRNA stabilization and transcriptional up-regulation | Q79884998 | ||
| Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice | Q80123636 | ||
| Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis | Q82097915 | ||
| P433 | issue | 2 | |
| P304 | page(s) | R59 | |
| P577 | publication date | 2012-03-12 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Inhibition of inflammation but not ankylosis by glucocorticoids in mice: further evidence for the entheseal stress hypothesis | |
| P478 | volume | 14 |
| Q36801704 | An Activin Receptor IA/Activin-Like Kinase-2 (R206H) Mutation in Fibrodysplasia Ossificans Progressiva |
| Q26775441 | Enthesopathies and enthesitis. Part 1. Etiopathogenesis |
| Q36525920 | Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes. |
| Q38145008 | Mechanistic insights from animal models of psoriasis and psoriatic arthritis. |
| Q30353254 | Polymorphism of HLA-B27: 105 subtypes currently known. |
| Q83841053 | Spondyloarthritis: Evidence from animal studies supports the 'entheseal stress' hypothesis of ankylosing spondylitis |
| Q60263332 | Wnt5a is expressed in spondyloarthritis and exerts opposite effects on enthesis and bone in murine organ and cell cultures |
Search more.